These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. New drugs for improving injury outcome in spinal cord injuries. Werner PC West J Med; 1997 Apr; 166(4):271-2. PubMed ID: 9168687 [No Abstract] [Full Text] [Related]
6. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. Bracken MB; Shepard MJ; Holford TR; Leo-Summers L; Aldrich EF; Fazl M; Fehlings MG; Herr DL; Hitchon PW; Marshall LF; Nockels RP; Pascale V; Perot PL; Piepmeier J; Sonntag VK; Wagner F; Wilberger JE; Winn HR; Young W J Neurosurg; 1998 Nov; 89(5):699-706. PubMed ID: 9817404 [TBL] [Abstract][Full Text] [Related]
7. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. Bracken MB; Shepard MJ; Holford TR; Leo-Summers L; Aldrich EF; Fazl M; Fehlings M; Herr DL; Hitchon PW; Marshall LF; Nockels RP; Pascale V; Perot PL; Piepmeier J; Sonntag VK; Wagner F; Wilberger JE; Winn HR; Young W JAMA; 1997 May; 277(20):1597-604. PubMed ID: 9168289 [TBL] [Abstract][Full Text] [Related]
9. Lack of effect of postinjury treatment with methylprednisolone or tirilazad mesylate on the increase in eicosanoid levels in the acutely injured cat spinal cord. Hall ED; Yonkers PA; Taylor BM; Sun FF J Neurotrauma; 1995 Jun; 12(3):245-56. PubMed ID: 7473799 [TBL] [Abstract][Full Text] [Related]
10. Clinical trials of pharmacotherapy for spinal cord injury. Geisler FH Ann N Y Acad Sci; 1998 Jun; 845():374-81. PubMed ID: 9668370 [TBL] [Abstract][Full Text] [Related]
11. Drug development in spinal cord injury: what is the FDA looking for? Hall ED J Rehabil Res Dev; 2003; 40(4 Suppl 1):81-91. PubMed ID: 15077652 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological treatment of acute spinal cord injury: how do we build on past success? Hall ED J Spinal Cord Med; 2001; 24(3):142-6. PubMed ID: 11585231 [TBL] [Abstract][Full Text] [Related]
13. [Methylprednisolone in the treatment of acute spinal cord injury has become more and more questioned]. Kronvall E; Sayer FT; Nilsson OG Lakartidningen; 2005 Jun 13-26; 102(24-25):1887-8, 1890. PubMed ID: 16044768 [TBL] [Abstract][Full Text] [Related]
14. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. Bracken MB; Shepard MJ; Collins WF; Holford TR; Young W; Baskin DS; Eisenberg HM; Flamm E; Leo-Summers L; Maroon J N Engl J Med; 1990 May; 322(20):1405-11. PubMed ID: 2278545 [TBL] [Abstract][Full Text] [Related]
15. Methylprednisolone in acute spinal cord injury: a tarnished standard. Miller SM J Neurosurg Anesthesiol; 2008 Apr; 20(2):140-2. PubMed ID: 18362778 [No Abstract] [Full Text] [Related]
16. Acute spinal cord injury: pharmacotherapy and drug development perspectives. Blight AR; Zimber MP Curr Opin Investig Drugs; 2001 Jun; 2(6):801-8. PubMed ID: 11572660 [TBL] [Abstract][Full Text] [Related]